A linear model for estimation of neurotransmitter response profiles from dynamic PET data

NeuroImage

Volumn 59, Issue 3, 2012, Pages 2689-2699

  Normandin, Marc D ^a,b,e   Schiffer, Wynne K ^c,f   Morris, Evan D ^a,b,d,g  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

^d Indiana University Purdue University Indianapolis   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basis functions; Compartmental modeling; Dopamine; Neurotransmitter; PET; Reference region; Tracer kinetics

Indexed keywords

DOPAMINE; METHAMPHETAMINE; NEUROTRANSMITTER; RACLOPRIDE C 11;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; DATA ANALYSIS; DOPAMINE RELEASE; LIGAND BINDING; MICRODIALYSIS; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PARAMETRIC TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; SIMULATION; STATISTICAL MODEL;

ALGORITHMS; ANIMALS; COMPUTER SIMULATION; DOPAMINE; DOPAMINE ANTAGONISTS; EXTRACELLULAR SPACE; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; MICRODIALYSIS; MODELS, NEUROLOGICAL; MODELS, STATISTICAL; NEUROTRANSMITTER AGENTS; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RADIOPHARMACEUTICALS; RATS;

EID: 84855430096     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.07.002     Document Type: Article

References (73)

1. Aalto S., Brück A., Laine M., Någren K., Rinne J.O. Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. J. Neurosci. 2005, 25:2471-2477.
2. Abi-Dargham A., Gil R., Krystal J., Baldwin R.M., Seibyl J.P., Bowers M., Van Dyck C.H., Charney D.S., Innis R.B., Laruelle M. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am. J. Psychiatry 1998, 155:761-767.
3. Akaike H. A new look at the statistical model identification. IEEE Trans. Autom. Control 1974, 19:716-723.
4. Akaike H. A Bayesian analysis of the minimum AIC procedure. Ann. Inst. Stat. Math. 1978, 30:9-14.
5. Alpert N.M., Badgaiyan R.D., Livni E., Fischman A.J. A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems. NeuroImage 2003, 19:1049-1060.
6. Alpert N.M., Reilhac A., Chio T.C., Selesnick I. Optimization of dynamic measurement of receptor kinetics by wavelet denoising. NeuroImage 2006, 30:444-451.
7. Aston J.A., Gunn R.N., Worsley K.J., Ma Y., Evans A.C., Dagher A. A statistical method for the analysis of positron emission tomography neuroreceptor ligand data. NeuroImage 2000, 12:245-256.
8. Badgaiyan R.D., Fischman A.J., Alpert N.M. Striatal dopamine release during unrewarded motor task in human volunteers. NeuroReport 2003, 14:1421-1424.
9. Badgaiyan R.D., Fischman A.J., Alpert N.M. Striatal dopamine release in sequential learning. NeuroImage 2007, 38:549-556.
10. Badgaiyan R.D., Fischman A.J., Alpert N.M. Explicit motor memory activates the striatal dopamine system. NeuroReport 2008, 19:409-412.
11. Breier A., Su T.P., Saunders R., Carson R.E., Kolachana B.S., de Bartolomeis A., Weinberger D.R., Weisenfeld N., Malhotra A.K., Eckelman W.C., Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method. Proc. Natl. Acad. Sci. 1997, 94:2569-2574.
12. Burnham K.P., Anderson D.R. Model Selection and Inference: A Practical Information-Theoretic Approach 1998, Springer-Verlag, New York.
13. Busto U.E., Redden L., Mayberg H., Kapur S., Houle S., Zawertailo L.A. Dopaminergic activity in depressed smokers: a positron emission tomography study. Synapse 2009, 63:681-689.
14. 11C]raclopride binding with continuous infusion. J. Cereb. Blood Flow Metab. 1997, 17:437-447.
15. Christian B.T., Lehrer D.S., Shi B., Narayanan T.K., Strohmeyer P.S., Buchsbaum M.S., Mantil J.C. Measuring dopamine neuromodulation in the thalamus: Using [F-18]fallypride PET to study dopamine release during a spatial attention task. NeuroImage 2006, 31:139-152.
16. Christian B.T., Vandehey N.T., Floberg J.M., Mistretta C.A. Dynamic PET denoising with HYPR processing. J. Nucl. Med. 2010, 51:1147-1154.
17. Constantinescu C.C., Bouman C., Morris E.D. Nonparametric extraction of transient changes in neurotransmitter concentration from dynamic PET data. IEEE Trans. Med. Imaging 2007, 26:359-373.
18. Cox S.M.L., Benkelfat C., Dagher A., Delaney J.S., Durand F., McKenzie S.A., Kolivakis T., Casey K.F., Leyton M. Striatal dopamine responses to intranasal cocaine self-administration in humans. Biol. Psychiatry 2009, 65:846-850.
19. Cramér H. Mathematical Method of Statistics 1946, Princeton University Press.
20. de la Fuente-Fernández R., Sossi V., Huang Z., Furtado S., Lu J.Q., Calne D.B., Ruth T.J., Stoessl A.J. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. Brain 2004, 127:2747-2754.
21. Endres C.J., Carson R.E. Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands. J. Cereb. Blood Flow Metab. 1998, 18:1196-1210.
22. 11C]raclopride: combined PET-microdialysis studies. J. Cereb. Blood Flow Metab. 1997, 17:932-942.
23. Evans A.H., Pavese N., Lawrence A.D., Tai Y.F., Appel S., Doder M., Brooks D.J., Lees A.J., Piccini P. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann. Neurol. 2006, 59:852-858.
24. Fisher R.A. Applications of "Student's" distribution. Metron 1925, 5:90-104.
25. Fisher R.A. Statistical Methods for Research Workers 1925, Oliver and Boyd, Edinburgh.
26. Fried I., Wilson C.L., Morrow J.W., Cameron K.A., Behnke E.D., Ackerson L.C., Maidment N.T. Increased dopamine release in the human amygdala during performance of cognitive tasks. Nat. Neurosci. 2001, 4:201-206.
27. Friston K.J., Holmes A.P., Worsley K.J., Poline J.P., Frith C.D., Frackowiak R.S.J. Statistical parametric maps in functional imaging: A general linear approach. Hum. Brain Mapp. 1995, 2:189-210.
28. Friston K., Malizia A., Wilson S., Cunningham V., Jones T., Nutt D. Analysis of dynamic radioligand displacement or "activation" studies. J. Cereb. Blood Flow Metab. 1997, 17:80-93.
29. Gosset [Student] W.S. The probable error of a mean. Biometrika 1908, 6:1-25.
30. Gunn R.N., Lammertsma A.A., Hume S.P., Cunningham V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. NeuroImage 1997, 6:279-287.
31. Ichise M., Liow J.S., Lu J.Q., Takano A., Model K., Toyama H., Suhara T., Suzuki K., Innis R.B., Carson R.E. Linearized reference tissue parametric imaging methods: Application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J. Cereb. Blood Flow Metab. 2003, 23:1096-1112.
32. 11C]raclopride. NeuroImage 2009, 47:1639-1648.
33. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27:1533-1539.
34. Joshi A., Fessler J.A., Koeppe R.A. Improving PET receptor binding estimates from Logan plots using principal component analysis. J. Cereb. Blood Flow Metab. 2008, 28:852-865.
35. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Dagher A., Jones T., Brooks D.J., Bench C.J., Grasby P.M. Evidence for striatal dopamine release during a video game. Nature 1998, 393:266-268.
36. Lammertsma A.A., Hume S.P. Simplified reference tissue model for PET receptor studies. NeuroImage 1996, 4:153-158.
37. Landaw E.M., DiStefano J.J. Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations. Am. J. Physiol. 1984, 246:R665-R677.
38. Laruelle M., Abi-dargham A., Gil R., Kegeles L., Innis R. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol. Psychiatry 1999, 46:56-72.
39. Madsen M.T. A simplified formulation of the gamma variate function. Phys. Med. Biol. 1992, 37:1597-1600.
40. Marota J.J., Mandeville J.B., Weisskoff R.M., Moskowitz M.a., Rosen B.R., Kosofsky B.E. Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in rat. NeuroImage 2000, 11:13-23.
41. Martinez D., Gil R., Slifstein M., Hwang D.R., Huang Y., Perez A., Kegeles L., Talbot P., Evans S., Krystal J., Laruelle M., Abi-Dargham A. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol. Psychiatry 2005, 58:779-786.
42. Martinez D., Narendran R., Foltin R.W., Slifstein M., Hwang D.R., Broft A., Huang Y., Cooper T.B., Fischman M.W., Kleber H.D., Laruelle M. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am. J. Psychiatry 2007, 164:622-629.
43. Mazoyer B.M., Huesman R.H., Budinger T.F., Knittel B.L. Dynamic PET data analysis. J. Comput. Assist. Tomogr. 1986, 10:645-653.
44. Mintun M.A., Raichle M.E., Kilbourn M.R., Wooten G.F., Welch M.J. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann. Neurol. 1984, 15:217-227.
45. Morris E.D., Fisher R.E., Alpert N.M., Rauch S., Fischman A.J. In vivo imaging of neuromodulation using positron emission tomography: Optimal ligand characteristics and task length for detection of activation. Hum. Brain Mapp. 1995, 3:35-55.
46. Morris E.D., Yoder K.K., Wang C., Normandin M.D., Zheng Q.H., Mock B., Muzic R.F., Froehlich J.C. ntPET: a new application of PET imaging for characterizing the kinetics of endogenous neurotransmitter release. Mol. Imaging 2005, 4:473-489.
47. Morris E.D., Normandin M.D., Schiffer W.K. Initial comparison of ntPET with microdialysis measurements of methamphetamine-induced dopamine release in rats: support for estimation of dopamine curves from PET data. Mol. Imaging Biol. 2008, 10:67-73.
48. Morris E.D., Constantinescu C.C., Sullivan J.M., Normandin M.D., Christopher L.A. Noninvasive visualization of human dopamine dynamics from PET images. NeuroImage 2010, 51:135-144.
49. Normandin M.D., Morris E.D. Temporal resolution of ntPET using either arterial or reference region-derived plasma input functions. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2006, 1:2005-2008.
50. Normandin M.D., Morris E.D. Estimating neurotransmitter kinetics with ntPET: A simulation study of temporal precision and effects of biased data. NeuroImage 2008, 39:1162-1179.
51. Olive M.F., Nannini M.A., Ou C.J., Koenig H.N., Hodge C.W. Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release. Eur. J. Pharmacol. 2002, 437:55-61.
52. Oswald L.M., Wong D.F., McCaul M., Zhou Y., Kuwabara H., Choi L., Brasic J., Wand G.S. Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacology 2005, 30:821-832.
53. Oswald L.M., Wong D.F., Zhou Y., Kumar A., Brasic J., Alexander M., Ye W., Kuwabara H., Hilton J., Wand G.S. Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release. NeuroImage 2007, 36:153-166.
54. Pappata S., Dehaene S., Poline J.B., Gregoire M.C., Jobert A., Delforge J., Frouin V., Bottlaender M., Dolle F., Di Giamberardino L., Syrota A. In vivo detection of striatal dopamine release during reward: A PET study with [11C]raclopride and a single dynamic scan approach. NeuroImage 2002, 16:1015-1027.
55. Parasrampuria D.A., Schoedel K.A., Schuller R., Gu J., Ciccone P., Silber S.A., Sellers E.M. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans. J. Clin. Pharmacol. 2007, 47:1476-1488.
56. Rao C. Information and the accuracy attainable in the estimation of statistical parameters. Bull. Calcutta Math. Soc. 1945, 37:81-89.
57. Sarter M., Bruno J., Parikh V. Abnormal neurotransmitter release in behavioral and cognitive disorders: toward concepts of dynamic and function-specific dysregulation. Neuropsychopharmacology 2007, 32:1452-1461.
58. Schwarz G. Estimating the dimension of a model. Ann. Stat. 1978, 6:461-464.
59. Spencer T.J., Biederman J., Ciccone P.E., Madras B.K., Dougherty D.D., Bonab A.A., Livni E., Parasrampuria D.A., Fischman A.J. PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am. J. Psychiatry 2006, 163:387-395.
60. 11C]raclopride PET study. Brain 2009, 132:1376-1385.
61. Volkow N.D., Swanson J.M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am. J. Psychiatry 2003, 160:1909-1918.
62. Volkow N.D., Mullani N., Gould L., Adler S.S., Guynn R.W., Overall J.E., Dewey S. Effects flow of acute measured alcohol intoxication with PET on cerebral blood. New York 1988, 24:201-209.
63. Volkow N.D., Ding Y.S., Fowler J.S., Wang G.J., Logan J., Gatley J.S., Dewey S., Ashby C., Liebermann J., Hitzemann R., Wolf A.P. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch. Gen. Psychiatry 1995, 456-463.
64. Volkow N.D., Ding Y.S., Fowler J.S., Wang G.J. Cocaine addiction: hypothesis derived from imaging studies with PET. J. Addict. Dis. 1996, 15:55-71.
65. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Hitzemann R., Chen A.D., Dewey S.L., Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997, 386:830-833.
66. Volkow N.D., Wang G.J., Fowler J.S., Fischman M., Foltin R., Abumrad N.N., Gatley S.J., Logan J., Wong C., Gifford A., Ding Y.S., Hitzemann R., Pappas N. Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain. Life Sci. 1999, 65:PL7-PL12.
67. Volkow N.D., Fowler J.S., Wang G.J., Ding Y.S., Gatley S.J. Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies. Eur. Neuropsychopharmacol. 2002, 12:557-566.
68. Wand G.S., Oswald L.M., McCaul M.E., Wong D.F., Johnson E., Zhou Y., Kuwabara H., Kumar A. Association of amphetamine-induced striatal dopamine release and cortisol responses to psychological stress. Neuropsychopharmacology 2007, 32:2310-2320.
69. 11C]raclopride: optimization and signal-to-noise considerations. J. Nucl. Med. 2000, 41:522-530.
70. Wu Y., Carson R.E. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J. Cereb. Blood Flow Metab. 2002, 22:1440-1452.
71. Yoder K.K., Wang C., Morris E.D. Change in binding potential as a quantitative index of neurotransmitter release is highly sensitive to relative timing and kinetics of the tracer and the endogenous ligand. J. Nucl. Med. 2004, 45:903-911.
72. Zhou Y., Endres C.J., Brasic J.R., Huang S.C., Wong D.F. Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model. NeuroImage 2003, 18:975-989.
73. Zhou Y., Chen M.K., Endres C.J., Ye W., Brasic J.R., Alexander M., Crabb A.H., Guilarte T.R., Wong D.F. An extended simplified reference tissue model for the quantification of dynamic PET with amphetamine challenge. NeuroImage 2006, 33:550-563.